Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: higher complication rate for oxaliplatin compared to Mitomycin C

scientific article published on 01 May 2006

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: higher complication rate for oxaliplatin compared to Mitomycin C is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/00015458.2006.11679897
P698PubMed publication ID16910003

P2093author name stringS Laurent
M Meurisse
B Detroz
A Rouers
P433issue3
P921main subjectoxaliplatinQ422327
peritoneal carcinomatosisQ2071182
P304page(s)302-306
P577publication date2006-05-01
P1433published inActa Chirurgica BelgicaQ15759234
P1476titleCytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: higher complication rate for oxaliplatin compared to Mitomycin C
P478volume106

Reverse relations

cites work (P2860)
Q34258723Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for patients with peritoneal carcinomatosis from colorectal cancer: a phase II study from a Chinese center
Q87416761Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial
Q60948065Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer
Q35678699Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: a translational approach to improve survival
Q43136067The integrity of colonic anastomoses following the intraperitoneal administration of oxaliplatin

Search more.